Predicting Premature Treatment Termination in Inpatient Psychotherapy: A Machine Learning Approach

Sponsor
University Hospital Heidelberg (Other)
Overall Status
Completed
CT.gov ID
NCT06042595
Collaborator
(none)
2,023
84

Study Details

Study Description

Brief Summary

The study aims to develop a prediction model of premature treatment termination in psychosomatic hospitals using a machine learning approach.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Psychotherapy

Detailed Description

The aim of the study is to identify risk factors that lead to or predict premature treatment termination in psychosomatic hospitals. In the long-term, the study shall help to develop more precise prediction models that can enhance communication between therapists and patients about potential dropout and- if necessary- adaption of treatment in using a feedback loop.

Since it is still not clear which variables play a major role in predicting treatment termination in psychosomatic hospitals, the study design is exploratory and includes a broad range of intake patient characteristics. The purpose of this study is hereby, to develop a prediction model based on the information that are routinely assessed at intake. Therefore, three kind of variables are planned to be included: (1) demographic and other clinical variables (e.g. age, gender, ICD-10 diagnoses), (2) psychological questionnaire data (e.g. PHQ, SF-12, EB-45, IIP-32, OPD-SFK), and (3) physiological data (e.g. routine laboratory data, blood pressure). For the study, all patients that started inpatient psychotherapy at the medical centre Heidelberg between 2015 and January 2022 will be included, resulting in a sample size of approximately N = 2000. As the average dropout rate based on meta analytical results is around 20%, one can assume that up to 400 patients prematurely dropped out of treatment.

To calculate the prediction model, it is planned to use a machine learning approach which is highly functional in big data sets. Using a Random Forest Model for binary outcomes (regular treatment length vs. premature treatment termination) it is envisioned to identify variables that contribute to the prediction of premature treatment termination at intake. Additionally, waiting list effects will be considered by taking into account the waiting duration between the initial intake interview and the moment of the hospital admission. Therefore, the study will, for the first time, investigate a prediction model for premature treatment termination in inpatient psychotherapy including clinically relevant physiological data as well as waiting time effects in preparation of the psychosomatic treatment.

Study Design

Study Type:
Observational
Actual Enrollment :
2023 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Predicting Premature Treatment Termination in Inpatient Psychotherapy: A Machine Learning Approach
Actual Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Jan 1, 2022
Actual Study Completion Date :
Jan 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Premature treatment termination (vs. treatment completion) [Premature treatment termination will be operationalized as a dummy variable. Regular treatment duration is 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continuous study enrolment (01/2015 - 01/2022).]

    Premature treatment termination will be classified based on the treatment duration. Classification will be made retrospectively for each patient based on the duration of the inpatient treatment and if applicable (duration < 49 days) on the hospital discharge letter to screen for reasons of the shorter treatment duration.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients of at least 18 years of age

  • included in inpatient psychotherapy treatment program in a hospital for psychosomatic medicine

  • provided information about admission and discharge date

Exclusion Criteria:
  • bipolar, acute psychotic or substance abuse disorder

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital Heidelberg

Investigators

  • Study Director: Ulrike Dinger-Ehrenthal, Prof. Dr., Department of Psychosomatic Medicine and Psychotherapy, Medical Faculty, Heinrich-Heine University Düsseldorf

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Simone Jennissen, Principal Investigator, University Hospital Heidelberg
ClinicalTrials.gov Identifier:
NCT06042595
Other Study ID Numbers:
  • Dropout-Prediction-2023
First Posted:
Sep 18, 2023
Last Update Posted:
Sep 18, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 18, 2023